One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) it has a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and manufacturing, capsule filling and devices.
Hovione's culture is based on innovation, quality and dependability. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Reputation,Quality Service
Other Competitive Advantages: The Specialist Integrated CDMO
专业的合同研发生产一体化CDMO服务商
End-to-end solutions in one site
一站式端到端
解决方案
Drug Substance
Particle Engineering
Drug Product
原料药
颗粒工程
制剂
Patents and Copyrights:
Business Type: Service Provider,Manufacturer
R&D capacity: Own Brand
Annual Turnover(USD):
Main Sales Markets: North America,Western Europe,Eastern Europe,Asia
Other Competitive Advantages: The Specialist Integrated CDMO
专业的合同研发生产一体化CDMO服务商
End-to-end solutions in one site
一站式端到端
解决方案
Drug Substance
Particle Engineering
Drug Product
原料药
颗粒工程
制剂
Audited Supplier
Pharma Sources Insight January 2025
